PRO1160 / Genmab 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PRO1160 / Genmab
NCT05721222: PRO1160 for Advanced Solid and Liquid Tumors (PRO1160-001)

Recruiting
1/2
134
US, RoW
PRO1160
ProfoundBio US Co.
Renal Cell Carcinoma, Nasopharyngeal Carcinoma, Non Hodgkin Lymphoma
04/24
04/25

Download Options